FDA Import Refusal AEK-5230984-4/21/1 — MSD PHARMACEUTICAL PVT LTD
The FDA refused shipment AEK-5230984-4/21/1 from MSD PHARMACEUTICAL PVT LTD (India) on Jun 14, 2024. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 14, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75